Results 251 to 260 of about 67,431 (260)

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Leukemia, 2008
Andreas Hochhaus, S L Goldberg, Selim Corm   +2 more
exaly  

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia

Leukemia, 2010
Shuichi Mizuta, Keitaro Matsuo, Toshiaki Yujiri   +2 more
exaly  

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

Nature Reviews Cancer, 2007
Ellen Weisberg, Paul W Manley, Andreas Hochhaus   +2 more
exaly  

Imatinib

Reactions Weekly, 2010
openaire   +1 more source

Dysregulation of bone remodeling by imatinib mesylate

Blood, 2010
Kate Vandyke, Stephen Fitter, Timothy P Hughes   +2 more
exaly  

Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

Leukemia, 2006
M B Rios, Elias Jabbour, Hagop Kantarjian   +2 more
exaly  

Drug monitoring of imatinib levels in patients undergoing therapy for chronic myeloid leukaemia: comparing plasma levels of responders and non-responders

European Journal of Clinical Pharmacology, 2009
N Singh, T Velpandian, Kumar L
exaly  

Imatinib

Reactions Weekly, 2019
openaire   +2 more sources

Imatinib

Reactions Weekly, 2017
openaire   +1 more source

Clinical Pharmacokinetics of Imatinib

Clinical Pharmacokinetics, 2012
exaly